Referenties
1Albright AL. Spasticity and movement disorders in cerebral palsy. J. Child Neurol. 1996;11 Suppl 1(Suppl 1):S1-4.
2Hutchinson R, Graham HK. Management of spasticity in children. In: Barnes MP, Johnson GR, eds. Upper Motor Neurone Syndrome and Spasticity: Clinical Management and Neurophysiology. 2 ed. Cambridge, UK: Cambridge University Press; 2008:214-239.
3Reid SM, Carlin JB, Reddihough DS. Distribution of motor types in cerebral palsy: how do registry data compare? Dev. Med. Child Neurol. 2011;53(3):233-238.
4Surveillance of Cerebral Palsy in Europe. Prevalence and characteristics of children with cerebral palsy in Europe. Dev Med Child Neural. 2002; Sept; 44:633-40.
5Kirby RS, Wingate MS, Van Naarden Braun Ket al. Prevalence and functioning of children with CP in 4 areas of the US in 2006: a report from the Autism and Developmental Disabilities Monitoring Network. Res in Dev Disabilities. 2011 ;32(2):462-469.
6Mayo Clinic. Cerebral Palsy. Available at: www.mayoclinic.com. Accessed March 2020.
7https://www.nhs.uk/conditions/cerebral-palsy/ Accessed March 2020.
8Patel DR, Neelakantan M, Pandher K, Merrick J. Cerebral palsy in children: a clinical overview. Transl Pediatr 2020;9(Suppl 1):S125-S135
9Hoving MA, van Raak EP, Spincemaille GH, et al; Dutch Study Group on Child Spasticity. Safety and one-year efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy. Eur J Paediatr Neurol. 2009;13(3):247-256